S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
NYSE:CRL

Charles River Laboratories International - CRL News Today

$245.09
+0.80 (+0.33%)
(As of 01/27/2023 08:54 PM ET)
Add
Compare
Today's Range
$240.14
$246.88
50-Day Range
$201.94
$252.55
52-Week Range
$181.36
$349.84
Volume
366,800 shs
Average Volume
498,217 shs
Market Capitalization
$12.47 billion
P/E Ratio
28.87
Dividend Yield
N/A
Price Target
$297.38
Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.



CRL Media Mentions By Week

CRL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRL
News Sentiment

1.32

0.71

Average
Medical
News Sentiment

CRL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRL Articles
This Week

6

4

CRL Articles
Average Week

SourceHeadline
marketbeat.com logoPersonal Capital Advisors Corp Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
marketbeat.com - January 27 at 9:12 AM
marketbeat.com logoMalaga Cove Capital LLC Acquires New Shares in Charles River Laboratories International, Inc. (NYSE:CRL)
marketbeat.com - January 26 at 10:44 AM
marketbeat.com logoPremier Fund Managers Ltd Has $21.10 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
marketbeat.com - January 23 at 9:32 AM
marketbeat.com logoGreat West Life Assurance Co. Can Sells 682 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
marketbeat.com - January 23 at 5:11 AM
finance.yahoo.com logoiVexSol® Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors
finance.yahoo.com - January 26 at 8:18 AM
MarketBeat logoBrokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $302.17
americanbankingnews.com - January 24 at 3:48 AM
msn.com logoCharles River's (CRL) New CDMO Tie-Up to Boost Clinical Trials
msn.com - January 20 at 2:52 PM
finance.yahoo.com logoCharles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
finance.yahoo.com - January 18 at 8:22 AM
finance.yahoo.com logoCharles River Launches CliniPrime Suite of GMP-Compliant Cellular Products
finance.yahoo.com - January 16 at 8:36 AM
finance.yahoo.com logoShould You Buy Charles River Laboratories (CRL) After Golden Cross?
finance.yahoo.com - January 12 at 3:03 PM
finance.yahoo.com logoCharles River Establishes eXpDNA™ Plasmid Manufacturing Platform to Expedite DNA Programs
finance.yahoo.com - January 12 at 8:35 AM
forbes.com logoCharles River Labs
forbes.com - January 11 at 9:26 AM
finance.yahoo.com logoHere's Why You Should Retain Charles River (CRL) Stock Now
finance.yahoo.com - December 28 at 12:42 PM
finance.yahoo.com logoCharles River (CRL) Benefits From Price Rise Amid FX Woe
finance.yahoo.com - December 20 at 9:58 AM
msn.com logoCharles River gains as Cambodia denies restrictions on monkey exports
msn.com - December 15 at 1:06 PM
finance.yahoo.com logo16 Large-Cap Stocks with Insider Buying
finance.yahoo.com - December 15 at 1:06 PM
finance.yahoo.com logoCharles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors
finance.yahoo.com - December 6 at 9:37 AM
finance.yahoo.com logoDoes Charles River Laboratories International, Inc. (NYSE:CRL) Create Value For Shareholders?
finance.yahoo.com - December 5 at 6:13 PM
finance.yahoo.com logoCharles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection
finance.yahoo.com - December 1 at 7:27 PM
seekingalpha.com logoCharles River drops after disclosing supply challenges for animal studies
seekingalpha.com - November 30 at 1:22 PM
finance.yahoo.com logoCharles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022
finance.yahoo.com - November 10 at 4:51 PM
finance.yahoo.com logoCharles River Laboratories expanding Memphis CDMO biotech facility
finance.yahoo.com - November 8 at 5:47 AM
finance.yahoo.com logoCharles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
finance.yahoo.com - November 7 at 11:41 AM
finance.yahoo.com logoAnalysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - October 26 at 2:24 PM
finance.yahoo.com logoAbbott's (ABT) Q3 Earnings Top Estimates, 2022 EPS View Up (Revised)
finance.yahoo.com - October 20 at 9:08 AM
finance.yahoo.com logoWhat's in Store for Thermo Fisher (TMO) in Q3 Earnings?
finance.yahoo.com - October 17 at 4:47 PM
finance.yahoo.com logoWalgreens Boots (WBA) Q4 Earnings Top, Operating Loss Concerns
finance.yahoo.com - October 13 at 3:23 PM
finance.yahoo.com logoWhat's in Store for Abbott Laboratories (ABT) in Q3 Earnings?
finance.yahoo.com - October 13 at 3:23 PM
finance.yahoo.com logoCharles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
finance.yahoo.com - October 11 at 9:06 PM
finance.yahoo.com logoCharles River's (CRL) New Launch to Boost Gene Therapy Workflow
finance.yahoo.com - October 11 at 4:05 PM
finance.yahoo.com logoCharles River Laboratories International's (NYSE:CRL) five-year earnings growth trails the decent shareholder returns
finance.yahoo.com - October 5 at 8:46 AM
benzinga.com logoBioIVT Announces Global eCommerce Collaboration...
benzinga.com - October 3 at 12:50 PM
it.tmcnet.com logoBioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services
it.tmcnet.com - October 3 at 12:50 PM
nasdaq.com logoCharles River Lab Gains 7%
nasdaq.com - September 30 at 12:53 PM
nasdaq.com logoFirst Week of May 2023 Options Trading For Charles River Laboratories International (CRL)
nasdaq.com - September 19 at 1:01 PM
finance.yahoo.com logoCharles River Laboratories to Present at Baird and Morgan Stanley Conferences
finance.yahoo.com - September 8 at 5:36 PM
finanznachrichten.de logoCharles River Laboratories International, Inc.: Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
finanznachrichten.de - September 6 at 9:43 AM
finance.yahoo.com logoCharles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
finance.yahoo.com - September 6 at 9:43 AM
finance.yahoo.com logoAt US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?
finance.yahoo.com - September 3 at 10:03 AM
nasdaq.com logoPossible bearish signals as Charles River Laboratories International, Inc. (NYSE:CRL) insiders disposed of US$2.5m worth of stock
nasdaq.com - August 27 at 8:25 PM
markets.businessinsider.com logoExpert Ratings for Charles River
markets.businessinsider.com - August 25 at 12:18 PM
nz.finance.yahoo.com logoCharles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product
nz.finance.yahoo.com - August 9 at 8:11 AM
seekingalpha.com logoCharles River Laboratories International, Inc. (CRL) CEO James Foster on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 3 at 3:23 PM
markets.businessinsider.com logoCharles River Labs Slashes FY22 Outlook; Q2 Adj. EPS Tops Estimates, Revenues Miss
markets.businessinsider.com - August 3 at 10:22 AM
finance.yahoo.com logoCharles River Laboratories (CRL) Beats Q2 Earnings Estimates
finance.yahoo.com - August 3 at 10:22 AM
finance.yahoo.com logoEarnings Preview: Organon (OGN) Q2 Earnings Expected to Decline
finance.yahoo.com - July 28 at 1:40 PM
morningstar.com logoCharles River Laboratories International Inc - Stock Valuation CRL
morningstar.com - July 19 at 7:46 PM
finance.yahoo.com logoThese 2 Stocks May Be Recession-Proof
finance.yahoo.com - July 11 at 5:31 PM
finance.yahoo.com logoCharles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
finance.yahoo.com - July 11 at 9:17 AM
finance.yahoo.com logoCano Health, Inc. (CANO) Stock Jumps 17.1%: Will It Continue to Soar?
finance.yahoo.com - July 7 at 8:28 AM
nasdaq.com logoCharles River (CRL) Signs saRNA-Based Vaccine Manufacture Deal
nasdaq.com - June 28 at 2:50 PM
finance.yahoo.com logoCharles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
finance.yahoo.com - June 23 at 9:05 AM
seekingalpha.com logoCharles River, ASC Therapeutics to make gene therapy ASC618 for treatment of hemophilia A
seekingalpha.com - June 13 at 2:04 PM
finance.yahoo.com logoWhy Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term
finance.yahoo.com - June 3 at 11:46 AM
Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

This page (NYSE:CRL) was last updated on 1/30/2023 by MarketBeat.com Staff